Skip to main content

GE HealthCare Technologies Inc.

corporate_fare Company Profile

GE HealthCare Technologies Inc.

GEHC·NASDAQ·Industrial Applications And Services·CIK 0001932393

GE HealthCare Technologies Inc. is a global healthcare solutions provider offering advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions. The company generates revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. With approximately 54,000 colleagues, GE HealthCare serves customers in over 160 countries, supported by a global team of approximately 9,700 sales professionals and 8,900 field service engineers. Its customers include hospitals, health systems, and researchers, encompassing public, private, academic, and government institutions. GE HealthCare Technologies Inc. is a Delaware corporation headquartered in Chicago, Illinois. On January 3, 2023, General Electric Company completed the spin-off of GE HealthCare. The company's business is organized into four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment includes five product lines and associated service capabilities: Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), Women's Health, and X-ray.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for GEHC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • GE HealthCare Issues FY Adjusted EPS Guidance of $4.80-$5.00
  • China Vice Premier Welcomes GE HealthCare, Pledges Deeper Cooperation
  • GE HealthCare Expands Global AI Breast Cancer Screening Access via DeepHealth Partnership
  • GE HealthCare Appoints Stryker CEO Kevin Lobo to Board, Two Directors Depart
  • GE HealthCare Files Annual 10-K, Details $2.3B Intelerad Acquisition, $200M Share Repurchase, and Legal Proceeding Update

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.63B
Net Income
$2.08B
Diluted EPS
$4.55
Gross Profit
$8.25B
Operating Income
$2.76B
Cash & Equivalents
$4.49B
Total Debt
$10B
Debt / Equity
0.96×
Net Margin
10.1%
Shares Outstanding
456M sh
Source: 10-K · filed 2026-02-04 · accession 0001932393-26-000007
$80.51 -0.16% today
52-week range · as of 2026-10-28 $58.75 – $89.77
Market cap
$36.46B
Volume
3.8M (0.9× avg)
3-mo avg 4M
Live data · 2026-11-22 12:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GEHC - Filings & News (Page 2)

GEHC
Apr 29, 2026, 6:20 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $68.65
Real-time Price: $80.51 info
Change: +$11.86 (+17%) info
Market Cap: $36.46B info
GEHC
Apr 21, 2026, 10:17 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $74.37
Real-time Price: $80.51 info
Change: +$6.14 (+8%) info
Market Cap: $36.46B info
GEHC
Apr 16, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $73.20
Real-time Price: $80.51 info
Change: +$7.31 (+10%) info
Market Cap: $36.46B info
GEHC
Mar 17, 2026, 9:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $71.55
Real-time Price: $80.51 info
Change: +$8.96 (+13%) info
Market Cap: $36.46B info
GEHC
Feb 04, 2026, 6:28 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $80.79
Real-time Price: $80.51 info
Change: -$0.280 (-0.35%) info
Market Cap: $36.46B info
GEHC
Feb 04, 2026, 6:25 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $80.79
Real-time Price: $80.51 info
Change: -$0.280 (-0.35%) info
Market Cap: $36.46B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets